IE 11 Not Supported

For optimal browsing, we recommend Chrome, Firefox or Safari browsers.

What’s Wrong With the Merck Drug, Molnupiravir?

Why the FDA should not approve the drug.

This past week the drug maker Merck announced that it has a new pill that can significantly reduce the impacts of COVID-19 if taken early in the infection — preventing serious illness and hospitalization.

All that sounds well and good, but here’s the “problems” with the drug:

  • It was developed using scientific trails and so it should not be trusted.
  • Getting it adopted for medical use will require the Food and Drug Administration (FDA) to approve it for treatment of COVID-19.
  • This is the same FDA that has approved three vaccines for use against the coronavirus. If they approved those, why should we trust this new drug?
  • What’s to say that this drug won’t make you sterile?
  • What’s to say that there is not something in the pill that allows Bill Gates to track your movements?
  • Who’s to say this isn’t a grand experiment, like in the past, by white people against minorities? Whites must be getting a different version of the pill.
  • Why do we even need a drug like this, if the COVID-19 pandemic is huge hoax?
  • If you are young and healthy, why would you need to worry about getting sick or dying. You’ll live to be over the age of 80, right?
  • Finally, and most importantly, Dr. Fauci has touted the good news that comes from the development and manufacture of this drug. This makes it very suspect by anyone without a brain.

For others who don’t have the questions above, here is a story from Oct. 3: “Fauci sees hope in new Merck drug.”
Eric Holdeman is a contributing writer for Emergency Management magazine and is the former director of the King County, Wash., Office of Emergency Management.
Special Projects
Sponsored Articles